-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Ankylosing spondylitis (AS) is a chronic inflammatory disease
.
Patients with AS have excess cardiovascular risk and are attributable to long-term systemic inflammation
Vascular myocardial infarction
Data was collected from NHIRD over a period of 15 years
.
The variables were analyzed using Pearson's chi-square test and Fisher's exact test
A total of 5905 AS patients were included, including 1181 (20%) patients with uveitis and 4724 (80%) patients without uveitis
.
The Kaplan-Meier method and log-rank test showed that the cumulative risk of acute myocardial infarction was significantly higher in the uveitis group than in the non-uveitis group (p<0.
Patients with uveitis had a higher rate of acute myocardial infarction, regardless of coexisting conditions
.
Compared with patients without uveitis, patients with uveitis had a higher risk of developing acute myocardial infarction
Uveitis is an important risk factor for acute myocardial infarction in AS patients
.
Physicians should be aware of the potential cardiovascular risk of uveitis in patients with AS, especially in combination with other traditional risk factors for AMI
Source: Lai YF, Lin TY, Chien WC, Uveitis as a Risk Factor for Developing Acute Myocardial Infarction in Ankylosing Spondylitis: A National Population-Based Longitudinal Cohort Study, Front Immunol 2021;12
Source: Lai YF, Lin TY, Chien WC, Uveitis as a Risk Factor for Developing Acute Myocardial Infarction in Ankylosing Spondylitis: A National Population-Based Longitudinal Cohort Study, Front Immunol 2021;12Leave a comment here